US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Perpetuals.com Ltd

3.34

+0.03000.91%

Post-market: 3.400.0600+1.80%19:30 EDT

Volume:16.77K

Turnover:55.36K

Market Cap:27.10M

PE:-0.67

High:3.60

Open:3.33

Low:3.20

Close:3.31

52wk High:8.83

52wk Low:2.42

Shares:8.11M

Float Shares:5.45M

Volume Ratio:0.30

T/O Rate:0.31%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.9964

EPS(LYR):-0.7902

ROE:-72.52%

ROA:-8.93%

PB:1.14

PE(LYR):-4.23

Loading ...

Overview Company News Filings

New Benchmark in Business Aviation Training: Sino Jet Academy Achieves International Dual Certification

Press Release: Unaudited Preliminary Results for the Year Ended December 31, 2025

Darts: PDC aims to reel in Big Fish sponsor in multi-million-pound deal

Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026

Perpetuals.com files patent for bias-removal architecture for AI agents

Perpetuals files US patent application for BayesShield AI bias-removal architecture

Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026

Perpetuals.com Director Michael Hilmer acquires shares worth $32,495

Press Release: Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million

Perpetuals.com amends filing, says share issuance under exchange deal completed

Perpetuals.com CEO Gruhn to present at Emerging Growth Conference

Press Release: Hadron Energy Secures U.S. Uranium Conversion Agreement with ConverDyn, Locking In Domestic Fuel Supply for the Halo Micro-Modular Reactor

Perpetuals.com FY25 H1 net loss widens to USD 970,943; revenue drops to USD 805,088

Perpetuals.com Ltd: Extends Bayesshield AI Into Healthcare to Address the Root Cause of Diagnostic Errors

THOMSON REUTERS

Hadron Energy submits PDC White Paper on Halo MMR to U.S. NRC

Perpetuals extends BayesShield AI into healthcare with BayesShield Clinical rollout

Perpetuals.com's BayesShield AI Platform to Be Deployed Across German UDS Research Centers

MT Newswires Live

Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform

Perpetuals Announces Partnership With German University of Digital Science to License AI Trading Platform

THOMSON REUTERS

Avacta CEO Christina Coughlin Named as One of In Vivo's 2026 Rising Leaders

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/PDC/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PDC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDC\",,,,,undefined,":{"symbol":"PDC","market":"US","secType":"STK","nameCN":"Perpetuals.com Ltd","latestPrice":3.34,"timestamp":1790798400000,"preClose":3.31,"halted":0,"volume":16769,"hourTrading":{"tag":"盘后","latestPrice":3.4,"preClose":3.34,"latestTime":"19:30 EDT","volume":522,"amount":1774.951,"timestamp":1790811003263,"change":0.06,"changeRate":0.017964,"amplitude":0.017964},"delay":0,"changeRate":0.00906344410876127,"floatShares":5452700,"shares":8114100,"eps":-4.996365,"marketStatus":"Not Yet Opened","change":0.03,"latestTime":"09-30 16:00:00 EDT","open":3.33,"high":3.595,"low":3.195,"amount":55355.210189800004,"amplitude":0.120846,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.996365,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":0,"adr":0,"adrRate":5,"listingDate":1690257600000,"exchange":"NASDAQ","adjPreClose":3.31,"preHourTrading":{"tag":"盘前","latestPrice":3.32,"preClose":3.31,"latestTime":"09:28 EDT","volume":100,"amount":332,"timestamp":1790774880021,"change":0.01,"changeRate":0.003021,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":3.4,"preClose":3.34,"latestTime":"19:30 EDT","volume":522,"amount":1774.951,"timestamp":1790811003263,"change":0.06,"changeRate":0.017964,"amplitude":0.017964},"volumeRatio":0.304591},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDC\",,,,,undefined,":{"symbol":"PDC","floatShares":5452700,"roa":"-8.93%","roe":"-72.52%","lyrEps":-0.790182,"volumeRatio":0.304591,"shares":8114100,"dividePrice":0,"high":3.595,"amplitude":0.120846,"preClose":3.31,"low":3.195,"week52Low":2.42,"pbRate":"1.14","psRate":"16.74","week52High":8.83,"institutionHeld":0,"latestPrice":3.34,"eps":-4.996365,"divideRate":0,"volume":16769,"delay":0,"ttmEps":-4.996365,"open":3.33,"prevYearClose":6.475,"prevWeekClose":3.28,"prevMonthClose":3.04,"prevQuarterClose":5.9,"fiveDayClose":4,"twentyDayClose":3.04,"sixtyDayClose":4.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PDC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-16","symbol":"PDC","defaultRemindTime":1715866200000,"type":"split","dateTimestamp":1715832000000,"forFactor":5,"toFactor":1,"ratio":5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PDC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PDC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PDC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PDC","date":"2026-09-29","current":-0.668486,"percent":0.982456,"low":-20.799035,"twenty":-13.721465,"median":-9.49577,"eighty":-7.666668,"high":-1.484564,"avg":-10.200083,"sd":3.288229,"marketCap":27182362},"quantilePoints":[{"date":"2026-01-23","current":-12.841505,"twenty":-12.726719,"median":-12.554539,"eighty":-12.382359,"marketCap":20820140},{"date":"2026-01-30","current":-9.396756,"twenty":-12.329049,"median":-11.675543,"eighty":-10.201718,"marketCap":15771446},{"date":"2026-02-06","current":-7.275042,"twenty":-12.149167,"median":-9.714799,"eighty":-8.086801,"marketCap":11897223},{"date":"2026-02-13","current":-8.985188,"twenty":-11.515878,"median":-8.985188,"eighty":-7.549471,"marketCap":15130827},{"date":"2026-02-20","current":-8.855994,"twenty":-10.87722,"median":-8.985188,"eighty":-7.579088,"marketCap":14673241},{"date":"2026-02-27","current":-8.742983,"twenty":-10.032842,"median":-8.830662,"eighty":-7.735212,"marketCap":14368184},{"date":"2026-03-06","current":-9.337263,"twenty":-10.032842,"median":-8.985188,"eighty":-8.021273,"marketCap":15191838},{"date":"2026-03-13","current":-9.688387,"twenty":-9.991079,"median":-9.288813,"eighty":-8.290652,"marketCap":15618918},{"date":"2026-03-20","current":-9.233278,"twenty":-9.991079,"median":-9.314811,"eighty":-8.348912,"marketCap":14993551},{"date":"2026-03-27","current":-9.069316,"twenty":-9.96573,"median":-9.348389,"eighty":-8.474222,"marketCap":14581724},{"date":"2026-04-02","current":-9.313761,"twenty":-9.884139,"median":-9.348389,"eighty":-8.689231,"marketCap":15008804},{"date":"2026-04-10","current":-9.533008,"twenty":-9.74834,"median":-9.359515,"eighty":-8.70742,"marketCap":15374872},{"date":"2026-04-17","current":-12.673274,"twenty":-9.884139,"median":-9.362202,"eighty":-8.546978,"marketCap":20438819},{"date":"2026-04-24","current":-13.088049,"twenty":-10.217704,"median":-9.396756,"eighty":-8.70742,"marketCap":21079438},{"date":"2026-05-01","current":-15.050104,"twenty":-11.793949,"median":-9.471088,"eighty":-8.745021,"marketCap":24648605},{"date":"2026-05-08","current":-14.948137,"twenty":-12.890814,"median":-9.496239,"eighty":-8.793369,"marketCap":24526582},{"date":"2026-05-15","current":-13.305836,"twenty":-13.354923,"median":-9.542177,"eighty":-8.845861,"marketCap":21598035},{"date":"2026-05-22","current":-11.365513,"twenty":-13.169042,"median":-9.675854,"eighty":-8.876909,"marketCap":21140450},{"date":"2026-05-29","current":-14.128136,"twenty":-13.74972,"median":-9.719101,"eighty":-8.895541,"marketCap":26275960},{"date":"2026-06-05","current":-12.076178,"twenty":-13.8801,"median":-9.813125,"eighty":-8.952904,"marketCap":22349404},{"date":"2026-06-12","current":-14.872027,"twenty":-13.8801,"median":-9.991079,"eighty":-9.00144,"marketCap":27440229},{"date":"2026-06-18","current":-14.520969,"twenty":-14.245743,"median":-10.18842,"eighty":-9.035091,"marketCap":26709707},{"date":"2026-06-26","current":-11.614912,"twenty":-14.356284,"median":-10.79484,"eighty":-9.128052,"marketCap":21276450},{"date":"2026-07-02","current":-13.769243,"twenty":-14.446364,"median":-10.952611,"eighty":-9.21958,"marketCap":25339979},{"date":"2026-07-10","current":-12.205639,"twenty":-14.446364,"median":-11.365513,"eighty":-9.239186,"marketCap":32585522},{"date":"2026-07-17","current":-8.962642,"twenty":-14.389601,"median":-10.952611,"eighty":-9.21958,"marketCap":23914115},{"date":"2026-07-24","current":-9.476284,"twenty":-14.254526,"median":-10.71246,"eighty":-9.09917,"marketCap":25065786},{"date":"2026-07-31","current":-9.145848,"twenty":-14.247303,"median":-10.285858,"eighty":-9.069924,"marketCap":24862550},{"date":"2026-08-07","current":-7.600862,"twenty":-14.243402,"median":-10.102078,"eighty":-8.962642,"marketCap":20797828},{"date":"2026-08-14","current":-7.895877,"twenty":-14.128136,"median":-9.96573,"eighty":-8.855994,"marketCap":21475282},{"date":"2026-08-21","current":-7.890223,"twenty":-13.901725,"median":-9.813125,"eighty":-8.565167,"marketCap":21543027},{"date":"2026-08-28","current":-7.54419,"twenty":-13.86583,"median":-9.719101,"eighty":-8.219559,"marketCap":20526847},{"date":"2026-09-04","current":-6.589647,"twenty":-13.865684,"median":-9.68212,"eighty":-8.074037,"marketCap":18358995},{"date":"2026-09-11","current":-7.149765,"twenty":-13.859725,"median":-9.551961,"eighty":-7.894746,"marketCap":20120374},{"date":"2026-09-18","current":-7.670838,"twenty":-13.787041,"median":-9.54288,"eighty":-7.752526,"marketCap":21340182},{"date":"2026-09-25","current":-1.685972,"twenty":-13.740832,"median":-9.505721,"eighty":-7.700224,"marketCap":29210896},{"date":"2026-09-29","current":-1.562954,"twenty":-13.721465,"median":-9.49577,"eighty":-7.666668,"marketCap":27182362}],"updateTime":1790813778704},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PDC\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2636121488","title":"New Benchmark in Business Aviation Training: Sino Jet Academy Achieves International Dual Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=2636121488","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636121488?lang=en_us&edition=fundamental","pubTime":"2026-05-20 16:35","pubTimestamp":1779266100,"startTime":"0","endTime":"0","summary":"HONG KONG, May 20, 2026 /PRNewswire/ -- Recently,Sino Jet Academy's two core training programs — The Corporate Jet Crew program and the Train-the-Trainer Program—each received full accreditation as a dual \"Provider of Training Excellence\" certification from the Professional Development Consortium .PDC is a research organization headquartered in the UK. Its CPD Standards Office has certified more than 800 organizations from over 30 countries to date. The \"Provider of Training Excellence\" certification is based on four core principles: the organization's overall structure and values; the design and delivery of learning content; the organization's mechanisms for maintaining standards and driving continuous improvement; and the overall customer experience and satisfaction . Sino Jet Academy's two programs successfully passed rigorous assessments at the same time, demonstrating that the company's training system and service quality have earned international recognition.Self-Set as the Bench","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2969940/Sino_Jet_New_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2969940/Sino_Jet_New_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/new-benchmark-in-business-aviation-training-sino-jet-academy-achieves-international-dual-certification-302777400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636708887","title":"Press Release: Unaudited Preliminary Results for the Year Ended December 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2636708887","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636708887?lang=en_us&edition=fundamental","pubTime":"2026-05-19 14:14","pubTimestamp":1779171240,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, May 19, 2026  -- Avacta Therapeutics , a clinical stage biopharmaceutical company developing pre|CISION, a tumor-activated oncology delivery platform today published its unaudited preliminary results for the 12 months ended December 31, 2025 .-- Increased momentum and strengthened position as a pure-play oncology. biopharmaceutical company by focusing on the Company's unique proprietary. pre|CISION peptide drug conjugate platform, with significant progress. -- First patient received treatment in FOCUS-01, a multicenter,open-label Phase 1 clinical trial of AVA6103 (FAP-Exd,-- The FOCUS-01 trial is enrolling patients with six advanced cancers. that were selected by leveraging our strategic collaboration with. -- Presented highly favorable data from multiple preclinical studies. compared to successful antibody drug conjugate, Enhertu. Also. presented further data comparing with another successful antibody. -- Updated preclinical and translational data presented at","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","BK4136","BK4585","LU1169590202.USD","BK4022","BK4588","IE00B3T34201.USD","R","BK4232","LU2463526074.USD","LU1487256676.USD","LU1169589451.USD","LU1481600234.SGD","IP","LU1481599808.USD","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634028156","title":"Darts: PDC aims to reel in Big Fish sponsor in multi-million-pound deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2634028156","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634028156?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:38","pubTimestamp":1778503119,"startTime":"0","endTime":"0","summary":"Darts is enjoying a boom thanks in part to the rise of Luke Littler Darts chiefs at the PDC are seeking a multi-million-pound deal to sponsor one of the game’s most iconic moments, the “Big Fish” checkout.The contract will guarantee a brand exposure every time someone makes a 170 checkout – the highest possible, comprising two treble 20s followed by a bullseye – at all Professional Darts Corporation events in the UK and overseas, including the flagship World Championships at Alexandra Palace.UK-headquartered agency Sporting Group International is leading the search for a sponsor and is understood to be seeking seven figures a year on a minimum 24-month contract from a brand in the consumer or lifestyle sector.“The ‘Big Fish’ sponsor is not just a naming rights opportunity, it’s a unique and powerful chance for a brand to own the most celebrated single moment in one of the world’s fastest-growing sports,” said SGI chief executive Adrian Wright.","market":"nz","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/05/GettyImages-2227156440-e1778502775947.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/05/GettyImages-2227156440-e1778502775947.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/darts-pdc-aims-to-reel-in-big-fish-sponsor-in-multi-million-pound-deal/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/darts-pdc-aims-to-reel-in-big-fish-sponsor-in-multi-million-pound-deal/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634289402","title":"Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634289402","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634289402?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:05","pubTimestamp":1778501100,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., May  11, 2026 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3291850/29076/en/Cellectar-Biosciences-to-Report-First-Quarter-Financial-Results-and-Host-a-Conference-Call-on-Thursday-May-14-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0472753341.HKD","BK4135","BK4218","LU2092937221.SGD","LU1923621640.USD","BK4585","LU2362541513.USD","LU2041044095.USD","BK4123","LU0175139822.USD","BK4120","LU1721428933.USD","LU0124676726.USD","LU2023250504.SGD","LU2089279066.USD","LU0347712357.USD","BK4588","LU0158827948.USD","LU2413666426.HKD","LU2106854487.HKD","LU2125910179.SGD","LU2362541273.HKD","WM","LU2028103732.USD","LU2362540622.SGD","LU1585245621.USD","PDC","LU1917777945.USD","LU1803068623.USD","LU2271345857.HKD","LU2355687059.USD","BK4533","BK4181","LU1974910355.USD","LU0289960550.SGD","BK4566","LU0069063385.USD","LU1989772923.USD","CNS","LU2089284900.SGD","LU1430594728.SGD","LU0289961442.SGD","LU2229751404.USD","LU2463526074.USD","CLRB","LU1892829315.USD","BK4534","HST","LU0094547139.USD","LU1623119135.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633140369","title":"Perpetuals.com files patent for bias-removal architecture for AI agents","url":"https://stock-news.laohu8.com/highlight/detail?id=2633140369","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633140369?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:56","pubTimestamp":1778158585,"startTime":"0","endTime":"0","summary":"Perpetuals.com (PDC) has filed a U.S. patent application covering BayesShield AI, a system that identifies which AI model or human expert performs ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/perpetuals-com-files-patent-for-bias-removal-architecture-for-ai-agents-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/perpetuals-com-files-patent-for-bias-removal-architecture-for-ai-agents-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4528","BK4588","PDC","BK4587","AIPO","BK4023","BK4551","BK4585","CHAT","ARTY","BK4543","AI","AGIX","BK4123","AIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633141050","title":"Perpetuals files US patent application for BayesShield AI bias-removal architecture","url":"https://stock-news.laohu8.com/highlight/detail?id=2633141050","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633141050?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:01","pubTimestamp":1778155317,"startTime":"0","endTime":"0","summary":"Perpetuals filed a U.S. patent application covering BayesShield AI, a real-time routing system designed to select best-performing AI model or human expert for a given decision context.System targets reliability gap between benchmark results and production performance, aiming to strengthen risk controls for enterprise agentic AI deployments.Framework continuously scores performance across decision “regimes,” then directs tasks to top performers only when conditions match prior results.Company positioned use cases across decision-heavy sectors such as financial trading, fraud detection, cybersecurity.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via Bus","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL8XLSGy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633906805","title":"Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633906805","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633906805?lang=en_us&edition=fundamental","pubTime":"2026-05-06 14:00","pubTimestamp":1778047200,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, May  06, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, \"the Company\", \"Avacta\"), a clinical stage biopharmaceutical company developing pre|CISION,a tumor-activated ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288498/0/en/Avacta-presents-new-comparisons-of-pre-CISION-payload-release-vs-approved-ADCs-and-AVA6207-dual-payload-delivery-at-Science-Day-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","TSI","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633926477","title":"Perpetuals.com Director Michael Hilmer acquires shares worth $32,495","url":"https://stock-news.laohu8.com/highlight/detail?id=2633926477","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633926477?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:11","pubTimestamp":1778011891,"startTime":"0","endTime":"0","summary":"Perpetuals.com director Michael Anthony Hilmer reported open-market purchases of 4,000 American depositary shares.Total reported buy prices ranged from USD 7.97 to USD 8.20 per ADS.Beneficial ownership rose to 4,000 ADS following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL7Kncsr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Perpetuals.com Director Michael Hilmer acquires shares worth $32,495","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633145449","title":"Press Release: Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633145449","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633145449?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:00","pubTimestamp":1777978800,"startTime":"0","endTime":"0","summary":"Oversubscribed Financing Led by Nantahala Capital with Participation from Balyasny Asset Management, Caligan Partners, Janus Henderson Investors, SilverArc Capital Management, Stonepine Capital Management, Empery Asset Management LP, StemPoint Capital LP and other Dedicated Healthcare Funds along with Members of the Executive Management Team. Financing of up to $140 Million Supports Confirmatory Study and NDA Filing for Accelerated Approval of Iopofosine I 131 in Waldenstrm Macroglobulinemia with the FDA. Andrew Gu of Nantahala Capital Management, LLC to Join the Company's Board of Directors Upon Closing. FLORHAM PARK, N.J., May 05, 2026  --  Cellectar Biosciences, Inc. , a late-stage clinical biopharmaceutical company focused on the discovery and development of targeted oncology therapies, today announced that it has entered into a securities purchase agreement with certain institutional investors, and an additional securities purchase agreement with certain members of management, to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0094547139.USD","BK4588","LU0158827948.USD","LU2089283258.USD","LU2413666426.HKD","LU0124676726.USD","BK4135","BK4099","LU2413666699.HKD","LU0069063385.USD","PDC","LU1939255532.USD","LU1989772840.SGD","LU2362541513.USD","LU2089284900.SGD","LU0175139822.USD","TM","03160","BK4585","LU2355687059.USD","LU0347712357.USD","BK4566","CNS","BK4555","LU1712237335.SGD","BK4533","LU1989772923.USD","LU2240825500.USD","WM","LU2229751404.USD","LU2238339852.HKD","BK4604","LU0511384066.AUD","BK4534","LU2125910336.SGD","LU2463526074.USD","LU2023250504.SGD","LU0472753341.HKD","LU0158827781.USD","LU1623119135.USD","LU1917777945.USD","CLRB","LU2362540622.SGD","BK4120","LU2111349929.HKD","LU2106854487.HKD","LU1923621640.USD","LU2023250843.SGD","LU2125910179.SGD","LU0289960550.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632647818","title":"Perpetuals.com amends filing, says share issuance under exchange deal completed","url":"https://stock-news.laohu8.com/highlight/detail?id=2632647818","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632647818?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:10","pubTimestamp":1777666254,"startTime":"0","endTime":"0","summary":"Perpetuals.com filed an amended Form 6-K to update disclosure on its share exchange with Perpetual Markets.Share issuance to Perpetual shareholders under Share Exchange Agreement dated Dec. 28, 2025 has been completed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL4y0LWm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631528634","title":"Perpetuals.com CEO Gruhn to present at Emerging Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2631528634","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631528634?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:01","pubTimestamp":1777550481,"startTime":"0","endTime":"0","summary":"Perpetuals.com CEO Patrick Gruhn is scheduled to present at Emerging Growth Conference on May 6, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL85Xt1t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631343006","title":"Press Release: Hadron Energy Secures U.S. Uranium Conversion Agreement with ConverDyn, Locking In Domestic Fuel Supply for the Halo Micro-Modular Reactor","url":"https://stock-news.laohu8.com/highlight/detail?id=2631343006","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631343006?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:01","pubTimestamp":1777550460,"startTime":"0","endTime":"0","summary":"Partnership with the only supplier of domestically produced commercial uranium hexafluoride (UF ) in the United States marks a pivotal fuel cycle milestone as Hadron advances toward the GigCapital7 shareholder vote scheduled for May 7, 2026 and closing its deSPACing at a market-aligned $600 million valuation, and the Company's Principal Design Criteria White Paper now before the NRC. Hadron Energy, Inc. , developer of the Halo Micro-Modular Reactor , today announced the signing of a Uranium Conversion Services Agreement with ConverDyn, GP, the marketing agent for the only commercial uranium hexafluoride (UF ) conversion facility in the United States, which is owned and operated by Solstice Advanced Materials . The Agreement secures a foundational and non-replicable step in Hadron's domestic nuclear fuel cycle, directly enabling both the first deployment of the Halo MMR and its scalable commercial rollout.ConverDyn, GP, President & CEO Malcolm Critchley and Hadron Energy, Inc. Founder &","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLR","BK4123","URNJ","URA","SETM","T43.SI","SRUUF","BK4585","BK6085","GIG","BK4606","PDC","BK4588","BK6515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630340310","title":"Perpetuals.com FY25 H1 net loss widens to USD 970,943; revenue drops to USD 805,088","url":"https://stock-news.laohu8.com/highlight/detail?id=2630340310","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630340310?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:36","pubTimestamp":1777322214,"startTime":"0","endTime":"0","summary":"Perpetuals.com net loss widened to JPY 149.57 million  for six months ended Oct. 31, 2025.Revenue fell 44.87% to JPY 124.02 million .Operating loss deepened to JPY 160.74 million .Cash climbed to JPY 666.93 million  as of Oct. 31, 2025, following a $5 million private placement completed Oct. 15, 2025.Management cited lower software and system development services revenue due to PocketRD shifting from initial development to maintenance, while NTT DOCOMO revenue declined on monthly work-volume fluctuations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securitie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL6Pmwjv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629078585","title":"Perpetuals.com Ltd:  Extends Bayesshield AI Into Healthcare to Address the Root Cause of Diagnostic Errors","url":"https://stock-news.laohu8.com/highlight/detail?id=2629078585","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629078585?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:29","pubTimestamp":1776889785,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4150WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629104923","title":"Hadron Energy submits PDC White Paper on Halo MMR to U.S. NRC","url":"https://stock-news.laohu8.com/highlight/detail?id=2629104923","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629104923?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:41","pubTimestamp":1776861692,"startTime":"0","endTime":"0","summary":"Hadron Energy announced the submission of its Principal Design Criteria White Paper for Hadron’s Halo Modular Microreactor to the U.S. Nuclear Regu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hadron-energy-submits-pdc-white-paper-on-halo-mmr-to-u-s-nrc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hadron-energy-submits-pdc-white-paper-on-halo-mmr-to-u-s-nrc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PDC","NRC","BK4196","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629045226","title":"Perpetuals extends BayesShield AI into healthcare with BayesShield Clinical rollout","url":"https://stock-news.laohu8.com/highlight/detail?id=2629045226","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629045226?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:00","pubTimestamp":1776859253,"startTime":"0","endTime":"0","summary":"Perpetuals extended BayesShield AI into healthcare, launching BayesShield Clinical for hospitals and clinics.Product targets diagnostic errors by identifying physicians with statistically stronger diagnostic accuracy by case type.European Institute of Management partnership set to support pilot deployments, trial design, and academic oversight via its PhD in Healthcare Studies program.Platform was developed in financial markets, trained on more than 11.7 billion retail trades, now positioned for broader clinical rollout.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL5qwrK7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629905160","title":"Perpetuals.com's BayesShield AI Platform to Be Deployed Across German UDS Research Centers","url":"https://stock-news.laohu8.com/highlight/detail?id=2629905160","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629905160?lang=en_us&edition=fundamental","pubTime":"2026-04-22 01:51","pubTimestamp":1776793879,"startTime":"0","endTime":"0","summary":"Perpetuals.com (PDC) has entered into a licensing agreement with the German University of Digital Science to integrate its BayesShield AI predictive intelligence platform across the university's resea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARTY","PDC","AIPO","AGIX","BK4123","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629362056","title":"Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2629362056","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629362056?lang=en_us&edition=fundamental","pubTime":"2026-04-22 00:00","pubTimestamp":1776787200,"startTime":"0","endTime":"0","summary":"Presentation of additional analyses from FAP-Exd (AVA6103) study shows robust activity in PDX models with low FAP expression and more favorable kinetic profile compared to the marketed antibody-drug c","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/21/3278250/0/en/Avacta-data-at-AACR-2026-underline-favorable-profile-of-AVA6103-and-advantages-of-pre-CISION-delivery-platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266512127.USD","BK4181","BK4218","ADC","BK4231","BK4080","CRC","PK","BK4123","LU0456854461.SGD","PDX","BK4213","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627294253","title":"Perpetuals Announces Partnership With German University of Digital Science to License AI Trading Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2627294253","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627294253?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:00","pubTimestamp":1776337201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nTUA6FFDCJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627443261","title":"Avacta CEO Christina Coughlin Named as One of In Vivo's 2026 Rising Leaders","url":"https://stock-news.laohu8.com/highlight/detail?id=2627443261","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627443261?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:26","pubTimestamp":1776165960,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, April  14, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, \"the Company\", \"Avacta\"), a clinical stage biopharmaceutical company developing pre|CISION,a tumor-activate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/14/3273220/0/en/Avacta-CEO-Christina-Coughlin-Named-as-One-of-In-Vivo-s-2026-Rising-Leaders.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":66,"code":"91000000","status":"200"}]}}